MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaip.2025.08.001

Медицинская библиотека · The journal of allergy and clinical immunology. In practice · 2025

HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions.

Li Yueran, Gibson Andrew, Saeed Hajirah N, Ashraf Mohammadali, Li Danmeng, Ostrov David A, Krantz Matthew S, Mallal Simon A, Alves Eric, Chopra Abha, Choo Linda, Dodiuk-Gad Roni P, Kaffenberger Benjamin, Drucker Aaron M, Goh Michelle S, Ergen Elizabeth, Micheletti Robert, Rosenbach Misha, Martin-Pozo Michelle D, Gangula Rama, Williams Elizabeth A, Yu Alexis, O'Connor April, Mahan Kelby, Kwan James T, Metcalfe Derek, Rashad Ramy, Shanbhag Swapna S, Tahboub Mohammed Ali, Pedretti Sarah, Choshi Phuti, Chimbetete Tafadzwa, Selim Rose, James Ian, Trubiano Jason A, Lehloenya Rannakoe, Peter Jonny G, Phillips Elizabeth J, SJS Survivor Study

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Co-trimoxazole is a leading global cause of severe cutaneous adverse drug reactions (SCAR) including Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS). Co-trimoxazole-induced SCAR are associated with HLA class I alleles including HLA-B∗13:01 and HLA-B∗38:02 in Southeast Asian (SEA) populations. However, the global generalizability of these associations is unknown but critical for population-appropriate risk stratification and diagnosis.

OBJECTIVE

To determine HLA risk factors associated with co-trimoxazole-induced SJS/TEN and DRESS in populations from the United States and South Africa.

METHODS

We performed high-resolution HLA typing on dermatologist-adjudicated co-trimoxazole-induced patients with SCAR in the United States (n = 63) and South Africa (n = 26) compared with population controls. Peptide binding and docking analyses were performed using MHCcluster2.0 and CB-Dock2.

RESULTS

In a multiple logistic regression model, HLA-B∗44:03 (corrected P [Pc] < .001; odds ratio [OR] = 4.08), HLA-B∗38:01 (Pc < .001; OR = 5.66), and HLA-C∗04:01 (Pc = .003; OR = 2.50) were independently associated with co-trimoxazole-induced SJS/TEN in the United States. HLA-B∗44:03 was also associated with co-trimoxazole-induced DRESS in South Africa (Pc = .019; OR = 10.69). Distinct HLA-B variants with shared peptide binding specificities (SPBS) and HLA-C∗04:01 identified 94% and 78% of co-trimoxazole-induced SJS/TEN and DRESS in the United States, respectively. The SEA risk allele HLA-B∗13:01, with SPBS to HLA-B∗44:03, was identified in just one of 63 US patients with SCAR.

CONCLUSIONS

HLA alleles with SPBS to SEA-related risk alleles, including HLA-B∗44:03 (SPBS with HLA-B∗13:01) and HLA-B∗38:01 (SPBS with HLA-B∗38:02) but also HLA-C∗04:01, predisposed to co-trimoxazole-induced SCAR in the United States and South Africa. These findings provide biological plausibility and strategies for global risk prediction and diagnosis of co-trimoxazole-induced SCAR.

Для цитирования: Li Yueran, Gibson Andrew, Saeed Hajirah N, Ashraf Mohammadali, Li Danmeng, Ostrov David A, Krantz Matthew S, Mallal Simon A, Alves Eric, Chopra Abha, Choo Linda, Dodiuk-Gad Roni P, Kaffenberger Benjamin, Drucker Aaron M, Goh Michelle S, Ergen Elizabeth, Micheletti Robert, Rosenbach Misha, Martin-Pozo Michelle D, Gangula Rama, Williams Elizabeth A, Yu Alexis, O'Connor April, Mahan Kelby, Kwan James T, Metcalfe Derek, Rashad Ramy, Shanbhag Swapna S, Tahboub Mohammed Ali, Pedretti Sarah, Choshi Phuti, Chimbetete Tafadzwa, Selim Rose, James Ian, Trubiano Jason A, Lehloenya Rannakoe, Peter Jonny G, Phillips Elizabeth J, SJS Survivor Study. HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions.. The journal of allergy and clinical immunology. In practice. 2025. DOI: 10.1016/j.jaip.2025.08.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.